Inflammatory and Genetic Diseases of the Aorta and Peripheral Vessels
Inflammatory changes to the aortic wall can be caused by a multitude of diseases. The broad spectrum of pathogenic factors and nonspecific clinical presentation often delay initial diagnosis; however, a precise determination of the underlying pathology is essential for successful management. The aim of this lecture is to describe the pathogenesis, symptoms and diagnosis of aortitis and equip healthcare providers with the knowledge required to perform adequate treatment following an appropriate diagnostic workup.
Cardiologists, Vascular Surgeons, Interventional Radiologists, Interventional Cardiologists, Primary Care Physicians, Podiatrists, Emergency Medicine Physicians, General Internists, Nurses, Advanced Practice Registered Nurses and other interested healthcare providers.
- Recognize the important imaging characteristics of large vessel vasculitis (Takayasu’s Arteritis, Giant Cell Arteritis, IgG4-Related Disease).
- Effectively identify patients with the three most common underlying genetic diseases of the aorta (Marfan Syndrome, Loeys-Dietz Syndrome, Ehler-Danlos Syndrome (Type IV).
- Implement evidence-based management strategies for inflammatory and genetic vascular diseases.
Jeffrey W. Olin, D.O., FACC, FAHA, MSVM
Professor of Medicine (Cardiology)
Director, Vascular Medicine and Vascular Diagnostic Laboratory
Zena and Michael A. Wiener Cardiovascular Institute and
Marie-Josée and Henry R. Kravis Center for Cardiovascular Health
Icahn School of Medicine at Mount Sinai
New York, N.Y.
Jeffrey W. Olin, D.O., faculty for this educational activity, has no relevant financial relationship with ineligible companies* to disclose and he will not include off-label or unapproved product usage in his presentation or discussion.
Conference Directors and Planning Committee Members
Barry T. Katzen, M.D., has indicated that he is a consultant for Boston Scientific, Philips Medical and W.L. Gore.
All of the relevant financial relationships listed for this individual have been mitigated.
Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose.
*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 General certificate of attendance
- 1.00 Nurse Practitioners
- 1.00 Florida Board of Nursing
- 1.00 Florida Board of Podiatric Medicine
This site is supported on the most recent stable releases of the following browsers:
This site is supported on the following mobile devices:
If you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.